We have investigated the photoprotective properties of induced pigmentation using erythema and epidermal DNA photodamage as endpoints. Previously unexposed buttock skin of 12 young, healthy adults (six skin type II and six skin type IV) was exposed daily (Monday to Friday) for 2 wk (days 1±12) with 0.65 minimal erythema dose of solar simulated radiation. Mean skin type IV minimal erythema dose was 1.8-fold greater than for skin type II. Compared to skin type II, solar simulated radiation treatments produced less erythema and more tanning in skin type IV. To assess DNA photodamage, biopsies were taken and prepared for paraf®n sections that were stained with a monoclonal antibody for thymine dimers. Thymine dimers were quanti®ed by image analysis. The single exposure data (0.65 and 2 minimal erythema dose) showed that DNA damage was related to physical dose (J per cm 2 ) independent of skin type. Our data also showed that DNA photodamage accumulates in both skin types with repeated, suberythemal doses of solar simulated radiation. On day 12, there were more thymine dimers in skin type IV than skin type II, again indicating that physical rather than biologic dose determines the level of DNA damage. Comparisons on days 12 and 19, however, showed a much greater loss of thymine dimers in skin type IV, suggesting better thymine dimer repair. Protection factors for erythema and thymine dimers were calculated and shown to be about 2 in both skin types. This provides further indirect evidence that DNA is a chromophore for erythema, but also suggests that a tan may not be the major factor in natural photoprotection.
We have investigated the photoprotective properties of induced pigmentation using erythema and epidermal DNA photodamage as endpoints. Previously unexposed buttock skin of 12 young, healthy adults (six skin type II and six skin type IV) was exposed daily (Monday to Friday) for 2 wk (days 1±12) with 0.65 minimal erythema dose of solar simulated radiation. Mean skin type IV minimal erythema dose was 1.8-fold greater than for skin type II. Compared to skin type II, solar simulated radiation treatments produced less erythema and more tanning in skin type IV. To assess DNA photodamage, biopsies were taken and prepared for paraf®n sections that were stained with a monoclonal antibody for thymine dimers. Thymine dimers were quanti®ed by image analysis. The single exposure data (0.65 and 2 minimal erythema dose) showed that DNA damage was related to physical dose (J per cm 2 ) independent of skin type. Our data also showed that DNA photodamage accumulates in both skin types with repeated, suberythemal doses of solar simulated radiation. On day 12, there were more thymine dimers in skin type IV than skin type II, again indicating that physical rather than biologic dose determines the level of DNA damage. Comparisons on days 12 and 19, however, showed a much greater loss of thymine dimers in skin type IV, suggesting better thymine dimer repair. Protection factors for erythema and thymine dimers were calculated and shown to be about 2 in both skin types. This provides further indirect evidence that DNA is a chromophore for erythema, but also suggests that a tan may not be the major factor in natural photoprotection. Key words: melanogenesis/protection factor/ thymine dimers. J Invest Dermatol 118: 825±829, 2002 T he skin is repeatedly exposed to solar ultraviolet radiation (UVR), which results in various deleterious effects including photoageing and skin cancer (Green et al, 1992) . Constitutively pigmented skin is more resistant to sunburn and skin cancer than``white'' skin (Kaidbey et al, 1979) . Within``white'' skin types, epidemiologic data show a higher incidence of skin cancer in fair skinned individuals who burn easily and do not tan readily (skin types I and II). UVR induces keratinocyte DNA mutations at speci®c sites such as adjacent pyrimidine bases (cytosine or thymine) and generates a distinct``signature'' mutation pattern, namely C ® T or C=C ® T=T at dipyrimidine sites (Wikonkal and Brash, 1999) . It has been shown that more than 50% of skin basal cell carcinomas contain UVR-induced``signature'' mutations at p53 sites that appear to be clustered in hotspots (Ziegler et al, 1993) . The mutation of genes that lead to a lack of nucleotide excision repair of DNA photolesions in xeroderma pigmentosum patients indicates a strong association between DNA photodamage and skin cancer (Kraemer et al, 1994; van Steeg and Kraemer, 1999) .
The skin responds to repeated exposure by tanning (especially in skin types III and IV who tan readily and burn rarely), which is the result of melanogenesis and associated stratum corneum thickening. Tanning is widely believed to be a photoprotective response of UVR-exposed skin, which decreases damage from subsequent UVR exposure (Kollias et al, 1991; Mawn and Fleischer, 1993; McGinley et al, 1998) . Much of the work to date on natural photoprotection, however, is based on constitutive pigmentation (McFadden et al, 1961; Young et al, 1985; Lookingbill et al, 1995; Lock-Andersen et al, 1997) . It has further been suggested that the signi®cance of stratum corneum in photoprotection may be greater in fair skinned individuals than in pigmented individuals , especially in albino or vitiliginous skin where the stratum corneum may represent the only source of protection. Some of our previous human studies show that repeated exposure of skin types I/II to suberythemal solar simulated radiation (SSR) affords no protection against DNA photodamage from a subsequent 2 minimal erythema dose (MED) of SSR. Modest photoprotection [protection factor (PF) of 2±3], however, was seen in skin types III/ IV (who developed a good tan) (Young et al, 1991; Potten et al, 1993) . DNA damage was measured in these studies either using an indirect measurement of DNA damage (unscheduled DNA synthesis) or directly using a monoclonal antibody to thymine dimers (T=T). There was good correlation between SSR dose and the levels of T=T in epidermal nuclei and the levels of T=T also correlated well with the levels of unscheduled DNA synthesis.
In this study we have investigated the photoprotective effects of tanning induced by repeated daily suberythemal SSR exposure. These tanning treatments were carried out over a 2 wk period, which may be considered as a``simulated beach holiday exposure'' during which, for example, sunscreens may have been used to minimize sunburn. We have selected skin types II and IV and the photoprotection endpoints we have used are the MED and DNA damage (T=T, a class of cyclobutane pyrimidine dimer). These studies have enabled us to determine PF that are analogous to the widely used sun protection factors (SPF) used to classify the photoprotective properties on sunscreens.
We have shown in unpublished pilot studies that DNA photodamage accumulates in skin types II and III with repeated, suberythemal doses of SSR. The accumulation of DNA photodamage at suberythemal UVB exposures has also been shown in uninvolved human skin of psoriatics undergoing photochemotherapy (Bataille et al, 2000) . This is an important factor to consider as the accumulation of unrepaired DNA damage may have serious implications for skin cancer risk.
In this study we have investigated two factors concerned with the tanning response in different human skin types: ®rst, the level of photoprotection a tan offers against erythema and DNA photodamage, and second the accumulation and repair of DNA damage in the acquisition of a tan.
MATERIALS AND METHODS
Volunteers The local ethics committee approved the study. Twelve healthy young people were selected on the basis of their constitutive skin color and a questionnaire on their responses to solar exposure. According to the Fitzpatrick classi®cation (Fitzpatrick, 1988) six volunteers were skin type II (burns easily, tans with dif®culty) and six were skin type IV (tans well, burns rarely). Mean age was 24 y T 7 (SD). Eight volunteers were male and four were female. All volunteers gave informed consent.
UVR source and dosimetry SSR was obtained from a 1000 W xenon arc solar simulator (Oriel, U.K.). The spectrum of this source has been previously published (Sheehan et al, 1998) . The irradiance over the 295±400 nm range was determined with a double-monochromator spectroradiometer (Bentham Instruments, Reading, U.K.) that had been calibrated against a deuterium source measured by the National Physics Laboratory (Teddington, Middlesex, U.K.). These data were used to calibrate a wide-band thermopile radiometer (Medical Physics, Dryburn Hospital, Durham, U.K.), which was used for routine calculation of exposure dose (295±400 nm) expressed as J per cm 2 . Multiplication of the SSR and U.K. (51°N) solar spectra with the Commission Internationale de L'E Â clairage (CIE) erythema action spectrum (McKinlay and Diffey, 1987) shows that 92% and 81%, respectively, of the effective erythema energy is UVB (280±320 nm).
Study protocol All exposures were given to previously unexposed buttock skin. The 24 h just perceptible MED was determined by a geometric exposure series of eight (1 cm Q 1 cm) sites using a 25% incremental dose series. Duplicate 6 Q 5 cm sites were exposed daily (Monday to Friday) for two consecutive weeks (days 1±12) with 0.65 individual MED of SSR (pilot studies had shown that this was a dose that was tolerated in skin type II without excessive cumulative erythema). In order to assess the erythema PF offered by the SSR-treated site, 1 wk after the ®nal SSR treatment (days 18 and 19) the 24 h MED was assessed on one 0.65 MED daily treated site and reassessed on one adjacent nontreated site. On day 19 biopsies were taken from (i) a nontreated site, (ii) an SSR-treated site, (iii) an SSR-treated site immediately following a 2 MED exposure, (iv) an untreated site immediately after 2 MED, and (v) an untreated site that had received a single 0.65 MED SSR exposure. A biopsy was also taken from (vi) a treated site immediately after the last tanning treatment (end of week 2) in order to assess DNA photodamage induced by the chronic exposure. Biopsy (vi) shows how much DNA photodamage is induced by the 10 Q 0.65 MED exposures. Biopsy (ii) shows how much residual DNA damage remains from the repeat exposures 1 wk later. Combined, the data from biopsies (vi) and (ii) give an indication of DNA photodamage repair or loss of lesions by desquamation. By comparing data from biopsies (iii) and (iv), we obtained a PF for DNA photodamage.
Evaluation of erythema and tanning during study Exposure sites were assessed daily before each SSR exposure for erythema and tanning by eye and with a re¯ectance meter (Dia-Stron, Andover, U.K.) during the tanning treatment and on days 18 and 19. To obtain background corrected data, background erythema and tanning readings from proximal, untreated sites were subtracted from the erythema and tanning readings from treated sites.
Assessment of T=T Biopsies taken as described above were processed for analysis of T=T. The details have been published elsewhere (Potten et al, 1993) . Brie¯y, 3 mm paraf®n sections were cut and immunostained with a monoclonal antibody for T=T (TDM-1) (Mori et al, 1991) , followed by a DAB-peroxidase immune reaction that gives a brown nuclear coloration. Nuclei were counterstained with thionine. The sections were analyzed quantitatively using the Discovery automated image analysis system (Beckton Dickinson, Leiden, The Netherlands). T=T assessments were made over all epidermal layers as we have previously shown no quantitative differences between the basal and suprabasal layers exposed to SSR. In each volunteer, the speci®c background mean optical density per nucleus (i.e., T=T levels from a sample of biopsy obtained from non-SSR exposed skin) was subtracted from the mean optical density of the SSR-exposed sites.
Data analyses and statistical methods For each volunteer, erythema and MED readings from exposed and nonexposed sites as well as biopsies from exposed and nonexposed sites were taken as described. In each case the ratio of MED or T=T level on pre-exposed sites to MED or T=T on nonexposed sites was calculated and expressed as the PF. The PF represents an increase in protection against SSR-induced erythema or DNA photodamage following repeat, suberythemal exposure. The PF was calculated using the same approach as that for the determination of SPF. Thus, per person, the PF for erythema and DNA damage on the chronically exposed sites was determined using the expression PF = (MED or T=T value on treated site)/(MED or T=T value on a nontreated site).
In each case, mean and SD were calculated for skin type II and skin type IV separately. Single paired t tests (two-tailed) were carried out to compare values from exposed and nonexposed sites.
RESULTS
The tanning treatment results in more erythema in skin type II and more tanning in skin type IV At the end of week 3 (day 19), the daily tanning treatment resulted in a light tan in skin types II and a light-moderate tan in skin types IV. The differences in quantitative data re¯ect these semiquantitative observations. The onset and duration of erythema and tanning in response to SSR treatment are shown in Figs 1(a) and 1(b), respectively. All readings were background corrected and so are relative to proximal, non-SSR-exposed sites. The degree of tanning was greater in skin type IV. In skin type II, there is a cumulative erythema peak on day 5, which matched observations by eye. The erythema is less prominent by day 12 and was not perceptible to the naked eye by day 19. In all cases, skin type IV showed a similar pattern but with lower levels of erythema and more evident tanning.
With both skin types there is a steady increase in melanin content as the study progressed. With skin type II volunteers, however, the melanin appears to decrease (not statistically signi®cant, p = 0.38) during the ®rst week and steadily rises during the second week. We have previously reported this in humans and mice (Kipp et al, 1998; Sheehan et al, 1998) . The reasons for this are not known.
DNA damage is related to physical SSR dose when administered as a single exposure or as repeat exposures Figure 2 shows that DNA damage increases with increasing SSR dose. Figure 2(a) shows the epidermal DNA damage induced by single exposures of 0.65 MED or 2 MED SSR in skin types II and IV. When biopsies are taken immediately after exposure, the data indicate that the amount of epidermal DNA damage per single biologic dose (0.65 MED or 2 MED) is related to the physical dose. Figure 2(b) shows the epidermal DNA damage induced by repeat exposures of 0.65 MED SSR in skin types II and IV when biopsies were taken immediately after the last tanning treatment dose. Cumulatively, the two skin type groups got the same biologic dose (10 daily exposures of 0.65 MED), but the data show that the higher amount of DNA damage in skin type IV appears to be related to higher physical dose.
Epidermal DNA damage is more persistent in skin type II than in skin type IV Figure 3 shows the levels of epidermal DNA photodamage immediately after the last tanning treatment and the levels of damage in those tanned sites 1 wk later. Figure 3(a) shows means of each skin type group. Figure 3(b) shows the individual volunteer data. In skin types IV, there was a signi®cant reduction (68.9%) in the amount of DNA damage in the tanned sites after 1 wk (p = 0.02). Skin type II displayed a smaller reduction (37.3%) in the amount of DNA damage after 1 wk but this was not signi®cant (p = 0.18). Skin type IV had higher levels of DNA damage induced by the tanning protocols than skin type II (although this was not signi®cant, p = 0.1) but generally repaired the damage better over the period of 1 wk.
The PF for DNA photodamage and erythema are the same and are independent of skin type Skin type IV showed slightly higher PF than skin type II for both erythema and DNA photodamage but the difference was not signi®cant (p = 0.3 for erythema and p = 0.23 for DNA). The PF data for erythema and DNA damage are shown in Fig 4. The initially assessed mean MED value did not change on the second assessment on untreated skin. There was no signi®cant difference between the PF for DNA and erythema in skin type II or IV (p = 0.99 and p = 0.83, respectively).
DISCUSSION
We have assessed the photoprotective properties of induced tanning in skin types II and IV using erythema and T=T as endpoints. Our protocol simulated``sensible tanning'' with daily suberythemal exposure to SSR and was designed to minimize the effects of erythema accumulating after a few exposures. During the SSR treatment there was a clear difference in response between the two skin types. As expected, skin types II showed more erythema than skin types IV who in turn showed a better tanning response. One week after the last tanning treatment, SSR-exposed and nontreated sites were challenged with 2 MED SSR and PF were determined for erythema and T=T. The results (Fig 4) showed that in all cases the PF were in the region of 2±3. The values were slightly higher in skin type IV but the differences were not signi®cant. The similarity of the PF against erythema and T=T supports the hypothesis that DNA is a major chromophore for erythema as suggested by Young et al (1998 Young et al ( , 2000 . The PF of about 2 against erythema con®rm our earlier studies in skin types II and III (Sheehan et al, 1998) . The lack of difference between skin types II and IV suggests that the protection afforded by the treatment was not dependent on the level of tan as there was, as expected, a marked difference in the tanning response of the two skin types. It has been reported that UVR-induced stratum corneum thickening is important in photoprotection (Kaidbey and Kligman, 1978; Gniadecka et al, 1996) . We did not assess stratum corneum thickening in this study, but we have previously shown no skin-type-dependent difference in the number of stratum corneum layers after repeated daily exposure to suberythemal SSR (Young et al, 1988) . We have previously shown, however, that tape-stripping to remove the stratum corneum had little effect on the protective properties of a tan against erythema in skin types II and III (Sheehan et al, 1998) .
The volunteers received the same cumulative biologic dose (6.5 MED) but the skin type IV group received a higher cumulative physical dose (50 J per cm 2 T 9) than those of skin type II (38 J per cm 2 T 8) As shown in Fig 2(b) , this resulted in higher levels of T=T in skin type IV when the skin was assessed on day 12. For a given single exposure dose there was also more T=T in skin type IV. This was more apparent with the 0.65 MED than the 2 MED that seems to be in a plateau region as we have previously reported with SSR (Young et al, 1996) . These results suggest that untanned skin in sun-sensitive skin types is not inherently more sensitive to cyclobutane pyrimidine dimer formation as has been previously reported (Xu et al, 2000) but that T=T induction is a simple function of UVR dose independent of skin type, even with the development of pigmentation as was the case with skin type IV.
We have previously shown slow T=T repair in skin type I/II after a single exposure of 2 MED SSR (Young et al, 1996) . Furthermore, we did not detect any skin-type-dependent differences in T=T repair after a single exposure to 2 MED SSR (Young et al, 1996) although we did see large interpersonal variation. Comparisons of samples at the end of the SSR treatment period and 1 wk post-SSR, however, show a 68.9% reduction in skin type IV compared with a 37.3% reduction in skin type II, despite the fact that skin type IV had almost 2-fold more T=T at the end of the SSR treatment period. This strongly suggests that repeat SSR exposure has induced DNA repair in skin type IV but not skin type II.
This proposed greater T=T repair in skin type IV is in accordance with the hypothesis of Gilchrest and Eller (1999) whose data suggest that DNA excision fragments or DNA repair intermediates are a trigger for melanogenesis. It has also been suggested that DNA damage stimulates pigmentation through upregulation of tyrosinase levels and that tanning is part of the eukaryotic SOS response (Eller et al, 1997) . Our data suggest that this response may only occur in skin types that tan well and that this may be the reason that they are more resistant to skin cancer rather than the protective properties of a tan per se.
We have previously shown that the erythemal response to repeated suberythemal SSR is greater and more persistent in skin type II than in skin type III (Sheehan et al, 1998) and in this study we have seen the same trend between skin type II and IV. It has been suggested by Holmes et al (1997) and others (Jung et al, 1980; Aubin et al, 1989 ) that persistent erythema may be an independent risk factor for the development of skin cancer. Wilson et al (1981) have shown that prolonged erythema from a single exposure is related to skin type. The cumulative response to repeated suberythemal exposures may be more relevant to risk assessment than a single exposure response as the former is more relevant to a real-life situation. We believe that DNA is the chromophore for erythema , which would mean that erythema is the consequence of DNA photolesions such as cyclobutane pyrimidine dimers. It is possible that the persistence of erythema in skin types I (Young et al, 1991) and II is due to the lack of DNA repair in these skin types compared with skin types III and IV. Here, it is interesting to note that skin-cancer-prone xeroderma pigmentosum patients who lack DNA repair capacity also show persistent erythema (Berg et al, 1998) .
The widespread and popular belief that a tan is photoprotective is often used to justify tanning. Our study shows that the protection afforded by repeat low dose SSR exposure is modest and does not seem to be related to tanning per se. Using tanning protocols with higher daily doses from a different SSR source, we have previously reported a lack of any protection from SSR-induced epidermal DNA damage in skin types I and II but PF of about 2 in skin types III and IV (Young et al, 1991; Potten et al, 1993) . The low level of photoprotection that we have observed suggests that any photoprotective bene®t afforded by a tan is outweighed by the photodamage incurred in its acquisition, especially in skin type II. It should be remembered, however, that our study sites had not previously been exposed to UVR. More constant exposure, along with time, may alter any risk±bene®t assessment. A PF of 2 may be considerable over a lifetime, reducing effective UVR dose by 50%, if the tan can be maintained with lower levels of solar exposure, especially in white skin types that tan well. The stimulation of Figure 4 . The PF for DNA photodamage and erythema are the same. Skin type IV showed slightly higher values than skin type II but the differences were not signi®cant for either endpoint or between skin types (p > 0.5). These data support the hypothesis that DNA is a chromophore for erythema. The error bars represent the SD. Figure 3 . DNA repair 1 wk postirradiation is better in skin type IV than skin type II. DNA damage levels in skin type IV (mean = 235 T 112) were higher than in skin type II (mean = 129 T 53). One week after the exposure period, however, there was no change in skin type II (p = 0.18) whereas there was a signi®cant reduction in skin type IV (p = 0.02). (a) The mean data; (b) the individual data. The individual data show evidence of one skin type IV that did not accumulate DNA damage during the treatment and one skin type II that repaired well. MOD±bg is the background corrected level of T=T. The error bars represent the SD. DNA repair by regular low level UVR exposure may be an important factor to consider in risk assessment and public health campaigns. The cumulative DNA damage incurred on acquiring and maintaining a tan, however, remains an important risk and must be considered very carefully.
